CLINICAL_TRIALS
trial_result
· 2013-06-14
Clinical Trial Update: An Efficacy and Safety Study of Golimumab in Participants With Ulcerative Colitis [Phase 2, Phase 3]
Summary
A Phase 2/3 study evaluating golimumab for ulcerative colitis was terminated, and results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Colitis, Ulcerative | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2013-06-14